This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Comcast's Gov't. Job Swap: Today's Outrage

Tauzin, a Louisiana Republican, was a driving force behind the passage of the Medicare Act of 2003, which critics said was a giveaway of billions a year to the pharmaceuticals industry. So even cherry flavoring couldn't cover the ugly taste of negotiations between the PhRMA industry group and Tauzin even as President George W. Bush signed the bill, and a couple of years later he was made president of the lobbying group.

Tauzin's legislation was reputed to be worth $1.2 trillion to the pharmaceuticals industry, and the Comcast-NBC Universal merger was only a $30 billion deal. Attwell Baker, then, has set a new standard only in speed and brazenness.

"No wonder the public is so nauseated by business as usual in Washington -- where the complete capture of government by industry barely raises any eyebrows," said Craig Aaron, president and CEO of Free Press, a nonprofit media reform group. "We hope -- but won't hold our breath -- that her replacement will be someone who is not just greasing the way for their next industry job."

Michael Powell, former chairman of the FCC, was quick to offer praise, though, in a statement released Wednesday with alarming promptness. "Meredith has been a great friend for many years and an outstanding public servant, as she has served with honor and integrity," said Powell, who after his time with the FCC became president and CEO of the National Cable and Telecommunications Association, an industry lobbyist.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CMCSA $59.64 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs